Latest Breaking News On - Aprea therapeutics - Page 1 : comparemela.com

Aprea Therapeutics (NASDAQ:APRE) Rating Reiterated by HC Wainwright

HC Wainwright reissued their buy rating on shares of Aprea Therapeutics (NASDAQ:APRE – Free Report) in a research report released on Tuesday, Benzinga reports. The firm currently has a $20.00 price objective on the stock. HC Wainwright also issued estimates for Aprea Therapeutics’ Q2 2024 earnings at ($0.58) EPS, Q3 2024 earnings at ($0.56) EPS, […]

Berndr seizingerAprea therapeutics incAprea therapeuticsFree reportGet free reportDirector berndAprea therapeutics daily

FY2028 EPS Estimates for Aprea Therapeutics, Inc (NASDAQ:APRE) Cut by Analyst

Aprea Therapeutics, Inc. (NASDAQ:APRE – Free Report) – Analysts at Wedbush reduced their FY2028 earnings per share estimates for Aprea Therapeutics in a research report issued to clients and investors on Tuesday, May 14th. Wedbush analyst R. Driscoll now forecasts that the company will post earnings of $0.77 per share for the year, down from […]

Berndr seizingerAprea therapeutics company profileAprea therapeutics incAprea therapeuticsFree reportAprea therapeuticGet free reportDirector berndAprea therapeutics dailyNasdaq apreEarnings estimates

APRE Stock Earnings: Aprea Therapeutics Beats EPS for Q1 2024

APRE Stock Earnings: Aprea Therapeutics Beats EPS for Q1 2024
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

Aprea therapeuticsPlace earnings

Aprea Therapeutics (NASDAQ:APRE) Receives Outperform Rating from Wedbush

Aprea Therapeutics (NASDAQ:APRE) Receives Outperform Rating from Wedbush
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Berndr seizingerAprea therapeutics incAprea therapeuticsGet free reportDirector berndAprea therapeutics daily

Aprea Therapeutics Announces Appointment of Nadeem Q Mirza, M D , M P H as Chief Medical Officer and Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Aprea Therapeutics Announces Appointment of Nadeem Q Mirza, M D , M P H as Chief Medical Officer and Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesOren giladNadeemq mirzaMike moyerCorporate medical affairs at verastem oncologyUniversity of punjabCompany board of directorsClinical development at salarius pharmaceuticalsUniversity of texas at houstonExchange commissionSecurities exchangeAmerica medical affairs at sanofi oncologyAprea therapeutics incChief medical officerAprea therapeuticsSenior vice president